Acyclovir Availability In US May Be Affected By India Export Restrictions
USP information suggests many firms in India, which is restricting exports of the antibiotic, as well as China, produce it for the US market.
You may also be interested in...
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.
Unlike diagnostics, EUAs for drugs are rare and the fact that there already are FDA-approved competitors for Bayer’s chloroquine phosphate product may make the decision more complicated.
Efficacy trials are under way and one supplier already has said it would restart production to meet the anticipated demand.